ADMA Biologics ADMA Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from ADMA Biologics’s reported figures.
Based on trailing twelve months.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's gross margin?
- ADMA Biologics (ADMA) reported gross margin of 61.3% in Q1 2026.
- How has ADMA Biologics's gross margin changed year-over-year?
- ADMA Biologics's gross margin increased by 16.5% year-over-year, from 52.6% to 61.3%.
- What is the long-term trend for ADMA Biologics's gross margin?
- Over 5 years (2020 to 2025), ADMA Biologics's gross margin has grown at a 4.9% compound annual growth rate (CAGR), from -45.2% to 57.4%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.